​
​

Seres Therapeutics (MCRB) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Seres Therapeutics Revenue Highlights

Latest Revenue (Y)

$126.33M

0

Main Segment (Y)

License And Service

Main Geography (Y)

License And Service

Seres Therapeutics Revenue by Period

Seres Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-1672.24%
2022-12-31--95.08%
2021-12-31-336.33%
2020-12-31--3.74%
2019-12-31-22.07%
2018-12-31--11.94%
2017-12-31-47.48%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31--

Seres Therapeutics generated $126.33M in revenue during NA 2023, up 1672.24% compared to the previous quarter, and up 446.90% compared to the same period a year ago.

Seres Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31--79.35%
2023-09-30--99.75%
2023-06-30--24328.54%
2023-03-31--153.54%
2022-12-31--71.69%
2022-09-30-183.22%
2022-06-30--18.55%
2022-03-31--79.32%
2021-12-31--94.30%
2021-09-30-2307.85%
2021-06-30--7.96%
2021-03-31--67.44%
2020-12-31-1139.52%
2020-09-30--76.56%
2020-06-30--26.18%
2020-03-31-7.44%
2019-12-31-8.41%
2019-09-30--43.89%
2019-06-30-71.17%
2019-03-31--31.12%
2018-12-31-17.38%
2018-09-30-96.34%
2018-06-30-16.14%
2018-03-31-29.94%
2017-12-31--86.72%
2017-09-30-663.60%
2017-06-30--0.03%
2017-03-31--0.69%
2016-12-31--76.67%
2016-09-30-333.26%
2016-06-30-10.85%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31--

Seres Therapeutics generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Seres Therapeutics Revenue Breakdown

Seres Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 19
License And Service-

Seres Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 19: License And Service (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 19Dec 18Sep 18Jun 18
License And Service----
Grant----

Seres Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 19: License And Service (100.00%).

Seres Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 19
License And Service-

Seres Therapeutics's latest annual revenue breakdown by geography, as of Dec 19: License And Service (100.00%).

Quarterly Revenue by Country

CountryDec 19Dec 18Sep 18Jun 18
License And Service----
Grant----

Seres Therapeutics's latest quarterly revenue breakdown by geography, as of Dec 19: License And Service (100.00%).

Seres Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
VCYTVeracyte--
NSTGNanoString--
MCRBSeres Therapeutics--
FATEFate Therapeutics--
SYRSSyros Pharmaceuticals--
IOVAIovance Biotherapeutics--

MCRB Revenue FAQ

What is Seres Therapeutics’s yearly revenue?

Seres Therapeutics's yearly revenue for 2023 was $126.32M, representing an increase of 1672.24% compared to 2022. The company's yearly revenue for 2022 was $7.13M, representing a decrease of -95.08% compared to 2021. MCRB's yearly revenue for 2021 was $144.93M, representing an increase of 336.33% compared to 2020.

What is Seres Therapeutics’s quarterly revenue?

Seres Therapeutics's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a -100.00% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). MCRB's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is Seres Therapeutics’s revenue growth rate?

Seres Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -12.84%, and for the last 5 years (2019-2023) was 266.11%.

What are Seres Therapeutics’s revenue streams?

Seres Therapeutics's revenue streams in c 19 are License And Service

What is Seres Therapeutics’s main source of revenue?

For the fiscal year ending Dec 19, the largest source of revenue of Seres Therapeutics was License And Service. This segment made a revenue of $27.19M, representing 100.00% of the company's total revenue.